STATE STREET CORP - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$75,113,395
-31.4%
4,682,880
-0.8%
0.00%
-33.3%
Q2 2023$109,478,862
+2.4%
4,722,988
+2.6%
0.01%0.0%
Q1 2023$106,925,808
-26.6%
4,602,919
-54.2%
0.01%
+50.0%
Q4 2022$145,692,676
+64.0%
10,040,846
+115.6%
0.00%
-33.3%
Q3 2022$88,861,000
+1.8%
4,657,263
-3.1%
0.01%
+20.0%
Q2 2022$87,292,000
-17.5%
4,804,157
+14.5%
0.01%0.0%
Q1 2022$105,745,000
-13.1%
4,196,225
-4.9%
0.01%
-16.7%
Q4 2021$121,727,000
-12.2%
4,410,403
+2.7%
0.01%
-14.3%
Q3 2021$138,680,000
+10.9%
4,294,833
+5.0%
0.01%0.0%
Q2 2021$125,051,000
+1.8%
4,089,305
+1.4%
0.01%0.0%
Q1 2021$122,855,000
+67.2%
4,034,657
+8.6%
0.01%
+75.0%
Q4 2020$73,475,000
+29.9%
3,715,530
-14.3%
0.00%0.0%
Q3 2020$56,566,000
-7.3%
4,337,882
-19.4%
0.00%0.0%
Q2 2020$61,016,000
+4.1%
5,380,598
+31.4%
0.00%
-20.0%
Q1 2020$58,614,000
-44.6%
4,096,003
+5.4%
0.01%
-28.6%
Q4 2019$105,823,000
+3.5%
3,886,276
+8.8%
0.01%
-12.5%
Q3 2019$102,291,000
-10.7%
3,572,866
-13.3%
0.01%
-11.1%
Q2 2019$114,517,000
-15.2%
4,122,289
+1.4%
0.01%
-18.2%
Q1 2019$134,965,000
+25.3%
4,065,222
+9.7%
0.01%
+10.0%
Q4 2018$107,741,000
-32.1%
3,706,264
+7.5%
0.01%
-16.7%
Q3 2018$158,626,000
+35.7%
3,448,412
+10.2%
0.01%
+20.0%
Q2 2018$116,917,000
+8.8%
3,128,672
-14.0%
0.01%
+11.1%
Q1 2018$107,468,000
-10.1%
3,636,669
+4.4%
0.01%
-10.0%
Q4 2017$119,608,000
+6.4%
3,482,608
+12.1%
0.01%0.0%
Q3 2017$112,425,000
+40.0%
3,107,409
-0.0%
0.01%
+42.9%
Q2 2017$80,311,000
+31.7%
3,108,062
-2.2%
0.01%
+40.0%
Q1 2017$60,988,000
+1.9%
3,176,426
-11.5%
0.01%
-16.7%
Q4 2016$59,836,000
-6.2%
3,589,079
+15.8%
0.01%0.0%
Q3 2016$63,809,000
-3.5%
3,100,595
+43.5%
0.01%
-14.3%
Q2 2016$66,133,000
-19.7%
2,161,148
-1.8%
0.01%
-22.2%
Q1 2016$82,349,000
-5.2%
2,200,112
+9.3%
0.01%0.0%
Q4 2015$86,840,000
+21.0%
2,012,011
+5.1%
0.01%
+12.5%
Q3 2015$71,749,000
-0.2%
1,914,373
-9.5%
0.01%0.0%
Q2 2015$71,910,000
+25.3%
2,115,615
+30.5%
0.01%
+33.3%
Q1 2015$57,370,000
+10.3%
1,620,644
+6.1%
0.01%
+20.0%
Q4 2014$52,035,000
-10.6%
1,527,824
+1.3%
0.01%
-16.7%
Q3 2014$58,193,000
-9.4%
1,508,664
-8.6%
0.01%
-14.3%
Q2 2014$64,256,000
+6.1%
1,650,977
-6.8%
0.01%0.0%
Q1 2014$60,553,000
-29.0%
1,771,124
-50.6%
0.01%
+40.0%
Q4 2013$85,346,000
+68.3%
3,587,939
+66.3%
0.01%
-16.7%
Q3 2013$50,697,000
+5.5%
2,157,395
+20.6%
0.01%0.0%
Q2 2013$48,072,0001,788,9920.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders